ArticleThe Journal of clinical investigation2011

Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells.

Claire M Connell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.